Sysmex Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SSMXF research report →
Companywww.sysmex.co.jp
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
- CEO
- Hisashi Ietsugu
- IPO
- 2009
- Employees
- 10,042
- HQ
- Kobe, JP
Price Chart
Valuation
- Market Cap
- $5.20B
- P/E
- 24.05
- P/S
- 1.71
- P/B
- 1.69
- EV/EBITDA
- 7.75
- Div Yield
- 2.76%
Profitability
- Gross Margin
- 51.14%
- Op Margin
- 12.43%
- Net Margin
- 7.09%
- ROE
- 7.27%
- ROIC
- 7.50%
Growth & Income
- Revenue
- $503.15B · -1.08%
- Net Income
- $35.68B · -33.52%
- EPS
- $57.52 · -33.17%
- Op Income
- $62.56B
- FCF YoY
- 7.61%
Performance & Tape
- 52W High
- $17.52
- 52W Low
- $7.97
- 50D MA
- $8.48
- 200D MA
- $10.21
- Beta
- 0.65
- Avg Volume
- 445
Get TickerSpark's AI analysis on SSMXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SSMXF Coverage
We haven't published any research on SSMXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SSMXF Report →